171 related articles for article (PubMed ID: 33614732)
1. Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy.
Feng L; Li W; Chao Y; Huan Q; Lu F; Yi W; Jun W; Binbin C; Na L; Shougang Z
Kidney Dis (Basel); 2021 Jan; 7(1):34-49. PubMed ID: 33614732
[TBL] [Abstract][Full Text] [Related]
2. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
[TBL] [Abstract][Full Text] [Related]
4. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
5. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
[TBL] [Abstract][Full Text] [Related]
6. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
7. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.
Liu N; Guo JK; Pang M; Tolbert E; Ponnusamy M; Gong R; Bayliss G; Dworkin LD; Yan H; Zhuang S
J Am Soc Nephrol; 2012 May; 23(5):854-67. PubMed ID: 22362908
[TBL] [Abstract][Full Text] [Related]
8. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
9. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation.
Hassan NME; Said E; Shehatou GSG
Life Sci; 2021 May; 272():119241. PubMed ID: 33600861
[TBL] [Abstract][Full Text] [Related]
10. Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis.
Liu F; Yu C; Qin H; Zhang S; Fang L; Wang Y; Wang J; Cui B; Hu S; Liu N; Zhuang S
J Cell Mol Med; 2021 May; 25(13):6103-14. PubMed ID: 33949772
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
[TBL] [Abstract][Full Text] [Related]
12. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis.
Bigaeva E; Stribos EGD; Mutsaers HAM; Piersma B; Leliveld AM; de Jong IJ; Bank RA; Seelen MA; van Goor H; Wollin L; Olinga P; Boersema M
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F117-F134. PubMed ID: 31736352
[TBL] [Abstract][Full Text] [Related]
14. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
Makled MN; El-Kashef DH
Life Sci; 2020 Jul; 253():117729. PubMed ID: 32348836
[TBL] [Abstract][Full Text] [Related]
15. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
16. Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis.
XIN BM; WANG XX; JIN W; YAN HM; CUI B; ZHANG XW; HUA F; YANG HZ; HU ZW
Acta Pharmacol Sin; 2010 Dec; 31(12):1583-92. PubMed ID: 21113175
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
18. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
20. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.
You YK; Luo Q; Wu WF; Zhang JJ; Zhu HJ; Lao L; Lan HY; Chen HY; Cheng YX
J Cell Mol Med; 2019 Aug; 23(8):5576-5587. PubMed ID: 31211499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
